212 related articles for article (PubMed ID: 16873237)
1. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.
Ulbrandt ND; Ji H; Patel NK; Riggs JM; Brewah YA; Ready S; Donacki NE; Folliot K; Barnes AS; Senthil K; Wilson S; Chen M; Clarke L; MacPhail M; Li J; Woods RM; Coelingh K; Reed JL; McCarthy MP; Pfarr DS; Osterhaus AD; Fouchier RA; Kiener PA; Suzich JA
J Virol; 2006 Aug; 80(16):7799-806. PubMed ID: 16873237
[TBL] [Abstract][Full Text] [Related]
2. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
3. A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.
Schuster JE; Cox RG; Hastings AK; Boyd KL; Wadia J; Chen Z; Burton DR; Williamson RA; Williams JV
J Infect Dis; 2015 Jan; 211(2):216-25. PubMed ID: 24864121
[TBL] [Abstract][Full Text] [Related]
4. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
[TBL] [Abstract][Full Text] [Related]
5. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model.
Hamelin ME; Gagnon C; Prince GA; Kiener P; Suzich J; Ulbrandt N; Boivin G
Antiviral Res; 2010 Oct; 88(1):31-7. PubMed ID: 20619294
[TBL] [Abstract][Full Text] [Related]
8. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
9. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
10. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
11. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
[TBL] [Abstract][Full Text] [Related]
12. Generation of temperature-sensitive human metapneumovirus strains that provide protective immunity in hamsters.
Herfst S; de Graaf M; Schrauwen EJA; Sprong L; Hussain K; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Jul; 89(Pt 7):1553-1562. PubMed ID: 18559924
[TBL] [Abstract][Full Text] [Related]
13. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
14. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
15. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
[TBL] [Abstract][Full Text] [Related]
16. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.
Xiao X; Tang A; Cox KS; Wen Z; Callahan C; Sullivan NL; Nahas DD; Cosmi S; Galli JD; Minnier M; Verma D; Babaoglu K; Su H; Bett AJ; Vora KA; Chen Z; Zhang L
MAbs; 2019; 11(8):1415-1427. PubMed ID: 31402751
[TBL] [Abstract][Full Text] [Related]
17. Serological cross-reactivity of members of the Metapneumovirus genus.
Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
[TBL] [Abstract][Full Text] [Related]
19. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
Williams JV; Chen Z; Cseke G; Wright DW; Keefer CJ; Tollefson SJ; Hessell A; Podsiad A; Shepherd BE; Sanna PP; Burton DR; Crowe JE; Williamson RA
J Virol; 2007 Aug; 81(15):8315-24. PubMed ID: 17522220
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.
Wen X; Mousa JJ; Bates JT; Lamb RA; Crowe JE; Jardetzky TS
Nat Microbiol; 2017 Jan; 2():16272. PubMed ID: 28134915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
